Weight-loss drugs in spotlight as pharma services firms rush to snap up business

Other companies specialising in parts of the manufacturing process for the injections are vying to get a bigger foothold by scaling up their capacity

A surge in sales of Novo Nordisk's drug Wegovy, which launched in the US in mid-2021, has propelled the Danish drugmaker to become Europe's most valuable company.

Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for firms that fill and assemble the self-injection pens.

A surge in sales of Novo Nordisk's drug Wegovy, which launched in the US in mid-2021, has propelled the Danish drugmaker to become Europe's most valuable company.